JP2020512356A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512356A5 JP2020512356A5 JP2019553173A JP2019553173A JP2020512356A5 JP 2020512356 A5 JP2020512356 A5 JP 2020512356A5 JP 2019553173 A JP2019553173 A JP 2019553173A JP 2019553173 A JP2019553173 A JP 2019553173A JP 2020512356 A5 JP2020512356 A5 JP 2020512356A5
- Authority
- JP
- Japan
- Prior art keywords
- cation
- alkyl
- methyl
- halogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001768 cations Chemical class 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 210000003205 muscle Anatomy 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762479256P | 2017-03-30 | 2017-03-30 | |
| US62/479,256 | 2017-03-30 | ||
| US201762559417P | 2017-09-15 | 2017-09-15 | |
| US62/559,417 | 2017-09-15 | ||
| PCT/US2018/025134 WO2018183668A1 (en) | 2017-03-30 | 2018-03-29 | Quinoline derived small molecule inhibitors of nicotinamide n-methyltransferase (nnmt) and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512356A JP2020512356A (ja) | 2020-04-23 |
| JP2020512356A5 true JP2020512356A5 (enExample) | 2021-05-06 |
| JP7359439B2 JP7359439B2 (ja) | 2023-10-11 |
Family
ID=63676960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553173A Active JP7359439B2 (ja) | 2017-03-30 | 2018-03-29 | ニコチンアミドｎ－メチルトランスフェラーゼ（ｎｎｍｔ）のキノリン由来小分子阻害剤及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11401243B2 (enExample) |
| EP (1) | EP3600317A4 (enExample) |
| JP (1) | JP7359439B2 (enExample) |
| AU (1) | AU2018244463B2 (enExample) |
| CA (1) | CA3057849A1 (enExample) |
| WO (1) | WO2018183668A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3057849A1 (en) * | 2017-03-30 | 2018-10-04 | The Board Of Regents Of The University Of Texas System | Quinoline derived small molecule inhibitors of nicotinamide n-methyltransferase (nnmt) and uses thereof |
| EP4010324B1 (en) | 2019-08-06 | 2023-09-06 | Eli Lilly and Company | Pyrimidine-5-carboxamide compound |
| CN114272236A (zh) * | 2020-09-27 | 2022-04-05 | 南京施江医药科技有限公司 | 用于判断线粒体氧化磷酸化通路抑制剂抗癌效果的标志物 |
| CN114644626A (zh) * | 2020-12-18 | 2022-06-21 | 南京施江医药科技有限公司 | 一种苯环类化合物及其应用 |
| CN116969885A (zh) * | 2023-08-01 | 2023-10-31 | 上海升德医药科技有限公司 | 一种5-氨基-1-烷基喹啉卤代物的合成工艺 |
| WO2025149628A1 (en) | 2024-01-12 | 2025-07-17 | Astrazeneca Ab | Piperidine derivatives as inhibitors of nicotinamide n-methyl transferase |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB846611A (en) * | 1958-02-07 | 1960-08-31 | Ici Ltd | Nitroquinolones |
| FR1588846A (enExample) * | 1965-07-25 | 1970-03-16 | ||
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| US4431774A (en) * | 1981-09-14 | 1984-02-14 | Ciba-Geigy Corporation | Process for the curing of stoving lacquers |
| US5817520A (en) * | 1991-12-20 | 1998-10-06 | Oxis International S.A. | Spectrophotometric methods for assaying total mercaptans, reduced glutathione (GSH) and mercaptans other than GSH in an aqueous medium reagents and kits for implementing same |
| DE10130144A1 (de) * | 2001-06-22 | 2003-01-02 | Wella Ag | 1-Benzopyran-Derivate und deren Salze enthaltende Färbemittel |
| US7977486B2 (en) * | 2006-09-08 | 2011-07-12 | Osaka University | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives |
| WO2012041493A1 (en) * | 2010-09-28 | 2012-04-05 | Julius-Maximilians-Universität Würzburg | Aminoquinolinium salts, methods of their production and their use as active agents for biotechnological and medical applications against binary toxins |
| WO2012150549A1 (en) * | 2011-05-03 | 2012-11-08 | Basf Se | Disulfide dyes |
| CA3057849A1 (en) * | 2017-03-30 | 2018-10-04 | The Board Of Regents Of The University Of Texas System | Quinoline derived small molecule inhibitors of nicotinamide n-methyltransferase (nnmt) and uses thereof |
-
2018
- 2018-03-29 CA CA3057849A patent/CA3057849A1/en active Pending
- 2018-03-29 WO PCT/US2018/025134 patent/WO2018183668A1/en not_active Ceased
- 2018-03-29 US US16/499,228 patent/US11401243B2/en active Active
- 2018-03-29 AU AU2018244463A patent/AU2018244463B2/en active Active
- 2018-03-29 EP EP18774649.0A patent/EP3600317A4/en active Pending
- 2018-03-29 JP JP2019553173A patent/JP7359439B2/ja active Active
-
2022
- 2022-06-07 US US17/834,847 patent/US12071409B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020512356A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2019535672A5 (enExample) | ||
| JP2017526726A5 (enExample) | ||
| JP2016121196A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| JP2019505529A5 (enExample) | ||
| JP2018021051A5 (enExample) | ||
| JP2017524025A5 (enExample) | ||
| RU2016134751A (ru) | Соединения | |
| JP2020507589A5 (enExample) | ||
| CN107427516B8 (zh) | 7-苄基-4-(2-甲基苄基)-2,4,6,7,8,9-六氢咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(1h)-酮、其类似物、及其盐、以及它们用于治疗的方法 | |
| JP2018536648A5 (enExample) | ||
| JP2005530811A5 (enExample) | ||
| CN114761411A (zh) | 作为erk抑制剂的螺环类化合物及其应用 | |
| JP2017517512A5 (enExample) | ||
| JP2017526677A5 (enExample) | ||
| JP2015523546A5 (enExample) | ||
| RU2016150326A (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
| JP2016531126A5 (enExample) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения |